COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab

J Allergy Clin Immunol. 2020 Jul;146(1):218-220.e2. doi: 10.1016/j.jaci.2020.05.005. Epub 2020 May 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Betacoronavirus
  • COVID-19
  • Chronic Disease
  • Comorbidity
  • Coronavirus Infections / epidemiology*
  • Female
  • Humans
  • Middle Aged
  • Nasal Polyps / epidemiology*
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • Rhinitis / drug therapy*
  • Rhinitis / epidemiology
  • SARS-CoV-2
  • Sinusitis / drug therapy*
  • Sinusitis / epidemiology

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab